Phase I/II trial of oral UFT/Leucovorin (LV) and paclitaxel (P) in the second line treatment of patients (PTS) with metastatic breast cancer (MBC)

被引：0
|
作者：
Klaassen, U [1 ]
Lang, S [1 ]
Borquez, D [1 ]
Oberhoff, C [1 ]
Benner, S [1 ]
Harstrick, A [1 ]
Seeber, S [1 ]
机构：
[1] Univ Essen Gesamthsch, W German Canc Ctr, Dept Int Med Canc Res, Essen, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81710-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1294
引用
收藏
页码：S322 / S323
页数：2
相关论文
共 50 条
  • [21] Oral uracil/tegafur (UFT) plus leucovorin (LV) in patients with metastatic colorectal cancer (CRC)
    Goker, E
    Aykan, NF
    Serdengecti, S
    Gunel, N
    Alakavuklar, M
    Icli, F
    Yucel, I
    Uskent, N
    Arpaci, F
    Firat, D
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S78
  • [22] A Phase I/II study of capecitabine (X) combined with oral vinorelbine IN) as first- or second-line chemotherapy in patients (pts) with locally advanced or metastatic breast cancer (MBC)
    Delcambre, C.
    Veyret, C.
    Levy, C.
    Switsers, O.
    Allouache, D.
    Raban, N.
    Grellard, J. M.
    Leconte, A.
    Delozier, T.
    EJC SUPPLEMENTS, 2005, 3 (02): : 118 - 118
  • [23] A PHASE I-II STUDY OF DASATINIB (D) IN COMBINATION WITH WEEKLY (W) PACLITAXEL (P) FOR PATIENTS (PTS) WITH METASTATIC BREAST CARCINOMA (MBC)
    Fornier, M. N.
    Morris, P. G.
    Abbruzzi, A.
    D'Andrea, G.
    Gilewski, T.
    Lake, D.
    Norton, L.
    Chang, J.
    Hudis, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 110 - 110
  • [24] A phase I/II study of oral capecitabine (X) and vinorelbine (V) as second- or -third line chemotherapy in anthracycline/taxane pretreated patients (pts) with metastatic breast cancer (MBC).
    Kellokumpu-Lehtinen, P
    Sjoström, J
    Sunela, K
    Lehtinen, I
    Joensuu, H
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S70 - S70
  • [25] First line chemotherapy with paclitaxel (P) and mitoxantrone (M) metastatic breast cancer (MBC). A phase II study
    Tsavdaridis, D
    Athanassiadis, A
    Kourtidou, P
    Hatzikonstantinou, N
    Saleh, M
    Hatzichristou, A
    Karapanagiotis, K
    Moschidis, A
    Liaros, A
    Apostolidis, A
    Harmouziadis, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S325 - S326
  • [26] ALL ORAL COMBINATION OF VINORELBINE AND CAPECITABILE AS A FIRST LINE TREATMENT IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC)
    Shehata, Samir
    Khalaf, Marwa
    BREAST, 2017, 36 : S53 - S53
  • [27] All oral combination of vinorelbine and capecitabine as a first line treatment in patients (pts) with metastatic breast cancer (MBC)
    Shehata, S.
    Khalaf, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] Final results of a phase II clinical and pharmacokinetical trial with oral idarubicin (IDA) in elderly patients (pts) with metastatic breast cancer (MBC).
    Crivellari, D
    Lombardi, D
    Sorio, R
    La Mura, N
    Massacesi, C
    Lucenti, A
    Ferro, A
    Veronesi, A
    Corona, G
    Toffoli, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 59S - 59S
  • [29] Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer
    Gelmon, KA
    OReilly, SE
    Tolcher, AW
    Campbell, C
    Bryce, C
    Ragaz, J
    Coppin, C
    Plenderleith, IH
    Ayers, D
    McDermott, B
    Nakashima, L
    Healey, D
    Onetto, N
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1185 - 1191
  • [30] Docetaxel: Evaluation of the activity and toxicity in second line of metastatic breast cancer (MBC) patients (PTS).
    Liguori, V
    Filice, A
    Biamonte, R
    Conforti, S
    Mastroianni, CM
    Rovito, A
    De Simone, R
    Manfredi, C
    Palazzo, S
    ANNALS OF ONCOLOGY, 2000, 11 : 44 - 44
12345